CLClinicLens

Unclassified

FDA Approves First Oral Carbapenem for Complicated UTIs | ClinicLens

The US Food and Drug Administration (FDA) approved the first oral carbapenem therapy for the treatment of complicated urinary tract infections (UTIs).

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.